Literature DB >> 17139162

Effect of formulation factors on in-vitro permeation of diclofenac from experimental and marketed aqueous eye drops through excised goat cornea.

Munish Ahuja1, Avinash Shridhar Dhake, Dipak Kanti Majumdar.   

Abstract

The effect of formulation factors on permeation of diclofenac from some experimental and marketed aqueous eye drops through excised goat cornea was evaluated. Raising the pH of formulation from 6.0 to 8.0 or diclofenac concentration from 0.05 to 0.15% (w/v) or adjusting tonicity with mannitol or addition of viscolizing agent decreased apparent permeability coefficient (Papp). Formulation (pH 7.4) containing sodium metabisulfite or EDTA or combination of methyl and propyl paraben showed significantly (p<0.05) higher Papp whereas benzalkonium chloride (BAC) had no effect and sorbic acid (SA) had reduced permeation. Surprisingly marketed drops containing BAC or SA, showed significantly (p<0.05) higher Papp and decreased in the order of Difen>Voveran>NSAID>Dicol>Diclolab. Lower pH (7.1-7.3) and surface tension of drops indicating presence of surfactant, could mediate increased permeation and presence of buffer could cause irritation on in vivo instillation. The marketed formulations showed corneal hydration >83% suggesting corneal damaging potential.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17139162     DOI: 10.1248/yakushi.126.1369

Source DB:  PubMed          Journal:  Yakugaku Zasshi        ISSN: 0031-6903            Impact factor:   0.302


  10 in total

1.  Ex vivo rabbit cornea diffusion studies with a soluble insert of moxifloxacin.

Authors:  María Sebastián-Morelló; María Aracely Calatayud-Pascual; Vicent Rodilla; Cristina Balaguer-Fernández; Alicia López-Castellano
Journal:  Drug Deliv Transl Res       Date:  2018-02       Impact factor: 4.617

2.  Topical ophthalmic lipid nanoparticle formulations (SLN, NLC) of indomethacin for delivery to the posterior segment ocular tissues.

Authors:  Sai Prachetan Balguri; Goutham R Adelli; Soumyajit Majumdar
Journal:  Eur J Pharm Biopharm       Date:  2016-10-25       Impact factor: 5.571

Review 3.  Cataract surgery and nonsteroidal antiinflammatory drugs.

Authors:  Richard S Hoffman; Rosa Braga-Mele; Kendall Donaldson; Geoffrey Emerick; Bonnie Henderson; Malik Kahook; Nick Mamalis; Kevin M Miller; Tony Realini; Neal H Shorstein; Richard K Stiverson; Barbara Wirostko
Journal:  J Cataract Refract Surg       Date:  2016-09       Impact factor: 3.351

4.  Management of ocular inflammation and pain following cataract surgery: focus on bromfenac ophthalmic solution.

Authors:  Hyung Cho; Kenneth J Wolf; Eric J Wolf
Journal:  Clin Ophthalmol       Date:  2009-06-02

Review 5.  Topical ocular delivery of NSAIDs.

Authors:  Munish Ahuja; Avinash S Dhake; Surendra K Sharma; Dipak K Majumdar
Journal:  AAPS J       Date:  2008-04-25       Impact factor: 4.009

6.  Etiology and treatment of the inflammatory causes of cystoid macular edema.

Authors:  Hyung Cho; Assumpta Madu
Journal:  J Inflamm Res       Date:  2009-10-02

7.  Effect of in vitro transcorneal approach of aceclofenac eye drops through excised goat, sheep, and buffalo corneas.

Authors:  Vivek Dave; Sarvesh Paliwal; Sachdev Yadav; Swapnil Sharma
Journal:  ScientificWorldJournal       Date:  2015-01-13

8.  Micelles of Progesterone for Topical Eye Administration: Interspecies and Intertissues Differences in Ex Vivo Ocular Permeability.

Authors:  Adrián M Alambiaga-Caravaca; María Aracely Calatayud-Pascual; Vicent Rodilla; Angel Concheiro; Alicia López-Castellano; Carmen Alvarez-Lorenzo
Journal:  Pharmaceutics       Date:  2020-07-26       Impact factor: 6.321

Review 9.  Ophthalmic Nanoemulsions: From Composition to Technological Processes and Quality Control.

Authors:  Agnieszka Gawin-Mikołajewicz; Karol P Nartowski; Aleksandra J Dyba; Anna M Gołkowska; Katarzyna Malec; Bożena Karolewicz
Journal:  Mol Pharm       Date:  2021-09-17       Impact factor: 4.939

10.  The short to medium-term risks of intracameral phenylephrine.

Authors:  Gwyn S Williams; Mahmoud Radwan; Shwan Kadare; Christopher P R Williams
Journal:  Middle East Afr J Ophthalmol       Date:  2012-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.